社区

Hey Tigers! Do you notice Pfizer's new play? Pfizer announced its acquisition of Arena Pharmaceuticals today in a $6.7 billion deal for the company’s research on inflammatory conditions affecting the stomach and intestine. Pfizer will pay Arena $100/share in cash. Shares of Arena stock nearly doubled yesterday as the company pursues treatments for ulcerative colitis and Crohn’s disease, as well as other dermatological, gastrointestinal, and cardiac conditions — Arena’s etrasimod drug for ulcerative colitis/Crohn’s is currently in late-stage trials. The acquisition’s timing is no coincidence as Pfizer also investigates treatments for gastrointestinal conditions. Pfizer is on a roll, lately. In addition to the o

What happened Shares of Apple ( AAPL 3.55% ) rose 3.5% to a record closing price of $171.18 on Tuesd

Hard-hit tech stocks include DocuSign, Adobe, Nvidia and Facebook Shares of these four tech-oriented

Tesla shares rose 1.4% in premarket trading. Tesla Inc said on Saturday it had delivered a record el

Yesterday it was cryptos, this morning it appears US equities are in line for the monkeyhammering. I

(Sept 7) Apple reached record high in early trading. Wedbush’s Dan Ives has made a bold prediction

Summary The US economy and stock market have benefitted from an unprecedented amount of stimulus in

One of two Wall Street analysts that had a sell rating on Apple stock threw in the towel. The other still thinks that AAPL shares could drop 40%. Is the sizable downside risk realistic?On the first day of September, one of the rare Wall Street bears on Apple stock finally gave in and dropped his sell rating. The last remaining one still sees shares dropping to a price target of $90, representing risk of loss of around 40%.Could New Street’s Pierre Ferragu, the last remaining Apple bear on Wall

India could offer Tesla Inc partial relief on import duties to get electric vehicles shipped to the